Lode, Holger N., Holko, Przemysław and Wieczorek, Aleksandra , (2025) Dinutuximab beta versus naxitamab in the treatment of re-lapsed/refractory neuroblastoma in patients with stable disease, minor response or partial response and disease in bone or bone marrow: systematic review and matching-adjusted indirect comparison. Cancers, 17 (17), [2723]. (doi:10.3390/cancers17172723).
Record type:
Article
Text
cancers-3808240
- Accepted Manuscript
Available under License Creative Commons Attribution.
Download (490kB)
Text
cancers-17-02723-v2
- Version of Record
Available under License Creative Commons Attribution.
Download (1MB)
More information
Accepted/In Press date: 15 August 2025
Published date: 22 August 2025
Keywords:
dinutuximab beta, matching-adjusted indirect comparison, naxitamab, relapsed/refractory neuroblastoma, systematic review
Identifiers
Local EPrints ID: 505283
URI: http://eprints.soton.ac.uk/id/eprint/505283
ISSN: 2072-6694
PURE UUID: 5e16388e-c31c-4a58-922c-a990a6892be2
Catalogue record
Date deposited: 06 Oct 2025 16:41
Last modified: 11 Oct 2025 01:44
Export record
Altmetrics
Contributors
Author:
Holger N. Lode
Author:
Przemysław Holko
Author:
Aleksandra Wieczorek
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.